SHENYANG, China, Aug. 20 /Xinhua-PRNewswire-FirstCall/ -- 3SBio Inc.
(Nasdaq: SSRX), a leading China-based biotechnology company focused on
researching, developing, manufacturing and marketing biopharmaceutical
products, today announced that the 2008 Annual General Meeting of Shareholders
of 3SBio Inc. will be held on September 12, 2008 (Friday) at 10:00 a.m.
(Beijing time) at No.3 A1, Road 10, Shenyang Economy & Technology Development
Zone, Shenyang 110027, People's Republic of China.
Further information is available on the 3SBio Inc. website at
http://www.3sbio.com under the heading "Investors", and additional information
about 3SBio Inc. is available in its annual report on Form 20-F for the year
ending December 31, 2007 filed with the U.S. Securities and Exchange
Commission, which can be accessed at the following link:
http://bbs.3sbio.com/en/News/ShowInfo_n16.aspx?ID=30 .
About 3SBio Inc.
3SBio Inc. is a leading, fully integrated biotechnology company focused on
researching, developing, manufacturing and marketing biopharmaceutical
products, primarily in China.
For further information, please contact:
Investor Contact:
Kevin Teo, CFO
3SBio Inc.
Tel: +86-24-2581-1820
Investor Relations (US):
Mahmoud Siddig
Taylor Rafferty
Tel: +1-212-889-4350
Investor Relations (HK):
Ruby Yim
Taylor Rafferty
Tel: +852-3196-3712
Media Contact:
Jason Marshall
Taylor Rafferty
Tel: +1-212-889-4350
.gif)
